LFCR

Business Context and Reporting Period

This Form 10-Q covers Landec Corporation (Note: The input metadata referenced "LIFECORE BIOMEDICAL, INC.", but the filing text explicitly identifies the registrant as Landec Corporation). The report covers the fiscal quarter ended August 31, 2008. Landec designs, develops, and sells temperature-activated polymer products for food, agriculture, and industrial applications. Its operations are divided into three segments: Food Products Technology (Apio), Commodity Trading, and Technology Licensing (including the Intellicoat seed coating agreement with Monsanto).

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Total revenues increased 15% year-over-year, driven by a 23% increase in Commodity Trading revenues and an 11% increase in Food Products Technology revenues.
• Net Income Decline: Despite higher revenues, Net Income decreased 8% to $2.84 million. This was primarily due to a significant increase in income tax expense ($1.91 million vs. $1.18 million) as the company utilized its net operating loss carryforwards, raising the effective tax rate to approximately 40%.
• Interest Income: Interest income dropped 54% to $357,000 due to lower yields on investments and a shift to more conservative investment portfolios.
• Segment Performance:
  • Food Products Technology: Revenues rose 11% to $43.8 million; Gross profit rose 17% to $7.3 million.
  • Commodity Trading: Revenues rose 23% to $26.3 million, largely due to an 84% increase in domestic sales to Wal-Mart and an 8% increase in export volumes.
  • Technology Licensing: Revenues remained relatively flat at $1.6 million.

Guidance, Outlook, and Risks

Management Commentary: Management attributes revenue growth to increased product offerings, new customers, and favorable harvest timing for domestic commodity sales. The company expects to continue experiencing fluctuations in quarterly results due to seasonality in the agricultural business and weather factors.

Liquidity: The company maintains a strong liquidity position with $45.7 million in cash and cash equivalents. It has a $7.0 million revolving line of credit with Wells Fargo, which had no outstanding balance as of August 31, 2008. Management believes current funds and cash flow are sufficient for the next 12 months.

Risks and Contingencies:

• Customer Concentration: The top five customers accounted for 49% of revenues, with Costco Wholesale Corp. alone representing 19%.
• Weather and Supply: Operations are subject to weather conditions affecting crop yields and commodity prices.
• Regulatory: Food packaging products are subject to FDA regulations; agricultural operations are subject to environmental laws and the Perishable Agricultural Commodities Act (PACA).
• Intellectual Property: The company relies on patents for its Intelimer and Intellicoat technologies and faces risks of infringement claims or failure to protect IP.

Investor Verification Checklist

• Customer Concentration: Verify the stability of the relationship with Costco (19% of revenue) and the top five customers (49% of revenue).
• Tax Rate Sustainability: Confirm the impact of the 40% effective tax rate on future profitability now that net operating loss carryforwards are exhausted.
• Commodity Trading Margins: Review the margin compression in the Commodity Trading segment, where revenue grew 23% but gross profit only grew 10% due to lower-margin domestic sales.
• Weather Exposure: Assess the potential impact of adverse weather conditions on the Apio produce supply chain and pricing.
• Monsanto Agreement: Monitor the status of the five-year license agreement with Monsanto, which provides significant recurring revenue and potential exit fees.